Semin Respir Crit Care Med 2007; 28(2): 182-192
DOI: 10.1055/s-2007-976490
Copyright © 2007 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Rhinovirus and Coronavirus Infections

Stephen B. Greenberg1
  • 1Department of Medicine, Baylor College of Medicine, Houston, Texas
Further Information

Publication History

Publication Date:
25 April 2007 (online)


Rhinoviruses and coronaviruses cause the majority of common colds and play a part in more serious respiratory illnesses that lead to increased morbidity and mortality. Patients who are infants or elderly, have asthma or chronic obstructive pulmonary disease (COPD), or are immunosuppressed have increased frequency of rhinovirus-related respiratory complications. Newer diagnostic tests such as reverse transcriptase polymerase chain reaction (RT-PCR) have greatly expanded our understanding of the importance of these respiratory viruses. Although there are no currently approved antiviral agents for clinical use, our increased understanding of the virus-host interaction should lead to new intervention strategies.


  • 1 Greenberg S B. Respiratory consequences of rhinovirus infection.  Arch Intern Med. 2003;  163 278-284
  • 2 Wat D. The common cold: a review of the literature.  Eur J Intern Med. 2004;  15 79-88
  • 3 Larson H E, Reed S E, Tyrrell D A. Isolation of rhinoviruses and coronaviruses from 38 colds in adults.  J Med Virol. 1980;  5 221-229
  • 4 Gwaltney Jr J M, Winther B, Patrie J T, Hendley J O. Combined antiviral-antimediator treatment for the common cold.  J Infect Dis. 2002;  186 147-154
  • 5 Gwaltney Jr J M, Phillips C D, Miller R D, Riker D K. Computed tomographic study of the common cold.  N Engl J Med. 1994;  330 25-30
  • 6 Whimbey E, Champlin R E, Couch R B et al.. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients.  Clin Infect Dis. 1996;  22 778-782
  • 7 Greenberg S B, Allen M, Wilson J, Atmar R L. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2000;  162 167-173
  • 8 El-Sahly H M, Atmar R L, Glezen W P, Greenberg S B. Spectrum of clinical illness in hospitalized patients with “common cold” virus infections.  Clin Infect Dis. 2000;  31 96-100
  • 9 Wedzicha J A. Role of viruses in exacerbations of chronic obstructive pulmonary disease.  Proc Am Thorac Soc. 2004;  1 115-120
  • 10 Johnston S L, Pattemore P K, Sanderson G et al.. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children.  BMJ. 1995;  310 1225-1229
  • 11 Hiatt P W, Grace S C, Kozinetz C A et al.. Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis.  Pediatrics. 1999;  103 619-626
  • 12 Chonmaitree T, Howie V M, Truant A L. Presence of respiratory viruses in middle ear fluids and nasal wash specimens from children with acute otitis media.  Pediatrics. 1986;  77 698-702
  • 13 Pitkäranta A, Virolainen A, Jero J, Arruda E, Hayden F G. Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction.  Pediatrics. 1998;  102 291-295
  • 14 Hayden F G. Rhinovirus and the lower respiratory tract.  Rev Med Virol. 2004;  14 17-31
  • 15 Greve J M, Davis G, Meyer A M et al.. The major human rhinovirus receptor is ICAM-1.  Cell. 1989;  56 839-847
  • 16 Marlovits T C, Abrahamsberg C, Blaas D. Soluble LDL minireceptors: minimal structure requirements for recognition of minor group human rhinovirus.  J Biol Chem. 1998;  273 33835-33840
  • 17 Uncapher C R, DeWitt C M, Colonno R J. The major and minor group receptor families contain all but one human rhinovirus serotype.  Virology. 1991;  180 814-817
  • 18 Yeager C L, Ashmun R A, Williams R K et al.. Human aminopeptidase N is a receptor for human coronavirus 229E.  Nature. 1992;  357 420-422
  • 19 Hofmann H, Pyrc K, van der Hoek L, Geier M, Berkhout B, Pohlmann S. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry.  Proc Natl Acad Sci USA. 2005;  102 7988-7993
  • 20 van der Hoek L, Pyrc K, Berkhout B. Human coronavirus NL63, a new respiratory virus.  FEMS Microbiol Rev. 2006;  30 760-773
  • 21 Williams R K, Jiang G S, Holmes K V. Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins.  Proc Natl Acad Sci USA. 1991;  88 5533-5536
  • 22 Lai M M, Holmes K V. Coronaviridae: the viruses and their replication. In: Knipe DM, Howley PM Fields Virology. Philadelphia, PA; Lippincott-Raven 2001: 641-663
  • 23 Haagmans B L, Osterhaus A D. Coronaviruses and their therapy.  Antiviral Res. 2006;  71 397-403
  • 24 Johnston S L. Overview of virus-induced airway disease.  Proc Am Thorac Soc. 2005;  2 150-156
  • 25 Jarjour N N, Gern J E, Kelly E A, Swenson C A, Dick C R, Busse W W. The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils.  J Allergy Clin Immunol. 2000;  105 1169-1177
  • 26 Johnston S L, Papi A, Bates P J, Mastronarde J G, Monick M M, Hunninghake G W. Low grade rhinovirus infection induces a prolonged release of IL-8 in pulmonary epithelium.  J Immunol. 1998;  160 6172-6181
  • 27 Griego S D, Weston C B, Adams J L, Tal-Singer R, Dillon S B. Role of p38 mitogen-activated protein kinase in rhinovirus-induced cytokine production by bronchial epithelial cells.  J Immunol. 2000;  165 5211-5220
  • 28 Laza-Stanca V, Stanciu L A, Message S D, Edwards M R, Gern J E, Johnston S L. Rhinovirus replication in human macrophages induces NF-kappaB-dependent tumor necrosis factor alpha production.  J Virol. 2006;  80 8248-8258
  • 29 Blau D M, Holmes K V. Human coronavirus HCoV-229E enters susceptible cells via the endocytic pathway.  Adv Exp Med Biol. 2001;  494 193-198
  • 30 Pyrc K, Jebbink M F, Berkhout B, van der Hoek L. Genome structure and transcriptional regulation of human coronavirus NL63.  Virol J. 2004;  1 7
  • 31 Callow K A, Parry H F, Sergeant M, Tyrrell D A. The time course of the immune response to experimental coronavirus infection of man.  Epidemiol Infect. 1990;  105 435-446
  • 32 Schmidt O W, Kenny G E. Immunogenicity and antigenicity of human coronaviruses 229E and OC43.  Infect Immun. 1981;  32 1000-1006
  • 33 Arruda E, Pitkäranta A, Witek Jr T J, Doyle C A, Hayden F G. Frequency and natural history of rhinovirus infections in adults during autumn.  J Clin Microbiol. 1997;  35 2864-2868
  • 34 Makela M J, Puhakka T, Ruuskanen O et al.. Viruses and bacteria in the etiology of the common cold.  J Clin Microbiol. 1998;  36 539-542
  • 35 Gonzales R, Malone D C, Maselli J H, Sande M A. Excessive antibiotic use for acute respiratory infections in the United States.  Clin Infect Dis. 2001;  33 757-762
  • 36 Hendley J O, Gwaltney Jr J M. Mechanisms of transmission of rhinovirus infections.  Epidemiol Rev. 1988;  10 243-258
  • 37 Tyrrell D A, Bynoe M L. Cultivation of viruses from a high proportion of patients with colds.  Lancet. 1966;  1 76-77
  • 38 Hamre D, Procknow J J. A new virus isolated from the human respiratory tract.  Proc Soc Exp Biol Med. 1966;  121 190-193
  • 39 McIntosh K, Dees J H, Becker W B, Kapikian A Z, Chanock R M. Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease.  Proc Natl Acad Sci USA. 1967;  57 933-940
  • 40 McIntosh K, Kapikian A Z, Turner H C, Hartley J W, Parrott R H, Chanock R M. Seroepidemiologic studies of coronavirus infection in adults and children.  Am J Epidemiol. 1970;  91 585-592
  • 41 Monto A S. Medical reviews: coronaviruses.  Yale J Biol Med. 1974;  47 234-251
  • 42 McIntosh K, Ellis E F, Hoffman L S, Lybass T G, Eller J J, Fulginiti V A. The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children.  J Pediatr. 1973;  82 578-590
  • 43 Monto A S. Epidemiology of respiratory viruses in persons with and without asthma and COPD.  Am J Respir Crit Care Med. 1995;  151 1653-1658
  • 44 Falsey A R, McCann R M, Hall W J et al.. The “common cold” in frail older persons: impact of rhinovirus and coronavirus in a senior daycare center.  J Am Geriatr Soc. 1997;  45 706-711
  • 45 Falsey A R, Walsh E E, Hayden F G. Rhinovirus and coronavirus infection-associated hospitalizations among older adults.  J Infect Dis. 2002;  185 1338-1341
  • 46 Peiris J S, Lai S T, Poon L L. SARS Study Group. Coronavirus as a possible cause of severe acute respiratory syndrome.  Lancet. 2003;  361 1319-1325
  • 47 van der Hoek L, Pyrc K, Jebbink M F et al.. Identification of a new human coronavirus.  Nat Med. 2004;  10 368-373
  • 48 Fouchier R A, Hartwig N G, Bestebroer T M et al.. A previously undescribed coronavirus associated with respiratory disease in humans.  Proc Natl Acad Sci USA. 2004;  101 6212-6216
  • 49 Esper F, Weibel C, Ferguson D, Landry M L, Kahn J S. Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children.  J Infect Dis. 2005;  191 492-498
  • 50 Woo P C, Lau S K, Chu C M et al.. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia.  J Virol. 2005;  79 884-895
  • 51 Esper F, Weibel C, Ferguson D, Landry M L, Kahn J S. Coronavirus HKU1 infection in the United States.  Emerg Infect Dis. 2006;  12 775-779
  • 52 Gerna G, Campanini G, Rovida F et al.. Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients.  J Med Virol. 2006;  78 938-949
  • 53 Garbino J, Crespo S, Aubert J D et al.. A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (non-SARS)-related human coronavirus infection.  Clin Infect Dis. 2006;  43 1009-1015
  • 54 Vijgen L, Keyaerts E, Lemey P et al.. Circulation of genetically distinct contemporary human coronavirus OC43 strains.  Virology. 2005;  337 85-92
  • 55 Dagher H, Donninger H, Hutchinson P, Ghildyal R, Bardin P. Rhinovirus detection: comparison of real-time and conventional PCR.  J Virol Methods. 2004;  117 113-121
  • 56 van Kraaij M G, van Elden L J, van Loon A M et al.. Frequent detection of respiratory viruses in adult recipients of stem cell transplants with the use of real-time polymerase chain reaction, compared with viral culture.  Clin Infect Dis. 2005;  40 662-669
  • 57 Vuorinen T, Vainionpaa R, Hyypia T. Five years' experience of reverse-transcriptase polymerase chain reaction in daily diagnosis of enterovirus and rhinovirus infections.  Clin Infect Dis. 2003;  37 452-455
  • 58 Loens K, Goossens H, de Laat C et al.. Detection of rhinoviruses by tissue culture and two independent amplification techniques, nucleic acid sequence-based amplification and reverse transcription-PCR, in children with acute respiratory infections during a winter season.  J Clin Microbiol. 2006;  44 166-171
  • 59 Lee B E, Robinson J L, Khurana V, Pang X L, Preiksaitis J K, Fox J D. Enhanced identification of viral and atypical bacterial pathogens in lower respiratory tract samples with nucleic acid amplification tests.  J Med Virol. 2006;  78 702-710
  • 60 van de Pol A C, Wolfs T F, Jansen N J, van Loon A M, Rossen J W. Diagnostic value of real-time polymerase chain reaction to detect viruses in young children admitted to the paediatric intensive care unit with lower respiratory tract infection.  Crit Care. 2006;  10 R61
  • 61 Beckham J D, Cadena A, Lin J et al.. Respiratory viral infections in patients with chronic, obstructive pulmonary disease.  J Infect. 2005;  50 322-330
  • 62 Schmidt O W. Antigenic characterization of human coronaviruses 229E and OC43 by enzyme-linked immunosorbent assay.  J Clin Microbiol. 1984;  20 175-180
  • 63 Kahn J S, McIntosh K. History and recent advances in coronavirus discovery.  Pediatr Infect Dis J. 2005;  24(Suppl 11) S223-S227
  • 64 Johnston S L, Pattemore P K, Sanderson G et al.. Community study of role of viral infections in exacerbations of asthma in 9-11-year-old children.  BMJ. 1995;  310 1225-1229
  • 65 Atmar R L, Guy E, Guntupalli K K et al.. Respiratory tract viral infections in inner-city asthmatic adults.  Arch Intern Med. 1998;  158 2453-2459
  • 66 Nicholson K G, Kent J, Ireland D C. Respiratory viruses and exacerbations of asthma in adults.  BMJ. 1993;  307 982-986
  • 67 Wark P A, Johnston S L, Moric I, Simpson J L, Hensley M J, Gibson P G. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma.  Eur Respir J. 2002;  19 68-75
  • 68 Corne J M, Marshall C, Smith S et al.. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study.  Lancet. 2002;  359 831-834
  • 69 Grunberg K, Timmers M C, de Klerk E P, Dick E C, Sterk P J. Experimental rhinovirus 16 infection causes variable airway obstruction in subjects with atopic asthma.  Am J Respir Crit Care Med. 1999;  160 1375-1380
  • 70 Calhoun W J, Dick E C, Schwartz L B, Busse W W. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects.  J Clin Invest. 1994;  94 2200-2208
  • 71 Fraenkel D J, Bardin P G, Sanderson G, Lampe F, Johnston S L, Holgate S T. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects.  Am J Respir Crit Care Med. 1995;  151 879-886
  • 72 Papadopoulos N G, Bates P J, Bardin P G et al.. Rhinoviruses infect the lower airways.  J Infect Dis. 2000;  181 1875-1884
  • 73 Gern J E, Galagan D M, Jarjour N N, Dick E C, Busse W W. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection.  Am J Respir Crit Care Med. 1997;  155 1159-1161
  • 74 Zhu Z, Tang W, Gwaltney Jr J M, Wu Y, Elias J A. Rhinovirus stimulation of interleukin-8 in vivo and in vitro: role of NF-kappaB.  Am J Physiol. 1997;  273 L814-L824
  • 75 Zhu Z, Tang W, Ray A et al.. Rhinovirus stimulation of interleukin-6 in vivo and in vitro: evidence for nuclear factor kappa B-dependent transcriptional activation.  J Clin Invest. 1996;  97 421-430
  • 76 Wark P A, Johnston S L, Bucchieri F et al.. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus.  J Exp Med. 2005;  201 937-947
  • 77 Cheung D, Dick E C, Timmers M C, de Klerk E P, Spaan W J, Sterk P J. Rhinovirus inhalation causes long-lasting excessive airway narrowing in response to methacholine in asthmatic subjects in vivo .  Am J Respir Crit Care Med. 1995;  152 1490-1496
  • 78 Smart J M, Horak E, Kemp A S, Robertson C F, Tang M L. Polyclonal and allergen-induced cytokine responses in adults with asthma: resolution of asthma is associated with normalization of IFN-gamma responses.  J Allergy Clin Immunol. 2002;  110 450-456
  • 79 Seymour M L, Gilby N, Bardin P G et al.. Rhinovirus infection increases 5-lipoxygenase and cyclooxygenase-2 in bronchial biopsy specimens from nonatopic subjects.  J Infect Dis. 2002;  185 540-544
  • 80 de Gouw H W, Grunberg K, Schot R, Kroes A C, Dick E C, Sterk P J. Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects.  Eur Respir J. 1998;  11 126-132
  • 81 Papadopoulos N G, Stanciu L A, Papi A et al.. A defective type 1 response to rhinovirus in atopic asthma.  Thorax. 2002;  57 328-332
  • 82 Sheppard P, Kindsvogel W, Xu W et al.. IL-28, IL-29 and their class II cytokine receptor IL-28R.  Nat Immunol. 2003;  4 63-68
  • 83 Contoli M, Message S D, Laza-Stanca V et al.. Role of deficient type III interferon-lambda production in asthma exacerbations.  Nat Med. 2006;  12 1023-1026
  • 84 Seemungal T, Harper-Owen R, Bhowmik A et al.. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2001;  164 1618-1623
  • 85 Smith C B, Golden C A, Kanner R E, Renzetti Jr A D. Association of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary diseases.  Am Rev Respir Dis. 1980;  121 225-232
  • 86 Rohde G, Wiethege A, Borg I et al.. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study.  Thorax. 2003;  58 37-42
  • 87 Keatings V M, Collins P D, Scott D M, Barnes P J. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.  Am J Respir Crit Care Med. 1996;  153 530-534
  • 88 Bandi V, Apicella M A, Mason E et al.. Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis.  Am J Respir Crit Care Med. 2001;  164 2114-2119
  • 89 Ishizuka S, Yamaya M, Suzuki T et al.. Effects of rhinovirus infection on the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells.  J Infect Dis. 2003;  188 1928-1939
  • 90 Passariello C, Schippa S, Conti C et al.. Rhinoviruses promote internalisation of Staphylococcus aureus into non-fully permissive cultured pneumocytes.  Microbes Infect. 2006;  8 758-766
  • 91 Sajjan U S, Jia Y, Newcomb D C et al.. H. influenzae potentiates airway epithelial cell responses to rhinovirus by increasing ICAM-1 and TLR3 expression.  FASEB J. 2006;  20 2121-2123
  • 92 Nokso-Koivisto J, Raty R, Blomqvist S et al.. Presence of specific viruses in the middle ear fluids and respiratory secretions of young children with acute otitis media.  J Med Virol. 2004;  72 241-248
  • 93 Heikkinen T, Chonmaitree T. Importance of respiratory viruses in acute otitis media.  Clin Microbiol Rev. 2003;  16 230-241
  • 94 Chantzi F M, Papadopoulos N G, Bairamis T et al.. Human rhinoviruses in otitis media with effusion.  Pediatr Allergy Immunol. 2006;  17 514-518
  • 95 Pitkäranta A, Roivainen M, Blomgren K et al.. Presence of viral and bacterial pathogens in the nasopharynx of otitis-prone children: a prospective study.  Int J Pediatr Otorhinolaryngol. 2006;  70 647-654
  • 96 Rihkanen H, Carpen O, Roivainen M, Vaheri A, Pitkäranta A. Rhinovirus in adenoid tissue.  Int J Pediatr Otorhinolaryngol. 2004;  68 903-908
  • 97 Elkhatieb A, Hipskind G, Woerner D, Hayden F G. Middle ear abnormalities during natural rhinovirus colds in adults.  J Infect Dis. 1993;  168 618-621
  • 98 McBride T P, Doyle W J, Hayden F G, Gwaltney Jr J M. Alterations of the eustachian tube, middle ear, and nose in rhinovirus infection.  Arch Otolaryngol Head Neck Surg. 1989;  115 1054-1059
  • 99 Sung B S, Chonmaitree T, Broemeling L D et al.. Association of rhinovirus infection with poor bacteriologic outcome of bacterial-viral otitis media.  Clin Infect Dis. 1993;  17 38-42
  • 100 Bulut Y, Guven M, Otlu B et al.. Acute otitis media and respiratory viruses.  Eur J Pediatr. 2007;  166 223-228
  • 101 Gwaltney Jr J M, Phillips C D, Miller R D, Riker D K. Computed tomographic study of the common cold.  N Engl J Med. 1994;  330 25-30
  • 102 Turner B W, Cail W S, Hendley J O et al.. Physiologic abnormalities in the paranasal sinuses during experimental rhinovirus colds.  J Allergy Clin Immunol. 1992;  90 474-478
  • 103 Gwaltney Jr J M. Acute community-acquired sinusitis.  Clin Infect Dis. 1996;  23 1209-1223
  • 104 Pitkäranta A, Arruda E, Malmberg H, Hayden F G. Detection of rhinovirus in sinus brushings of patients with acute community-acquired sinusitis by reverse transcription-PCR.  J Clin Microbiol. 1997;  35 1791-1793
  • 105 Gwaltney Jr J M, Hendley J O, Phillips C D, Bass C R, Mygind N, Winther B. Nose blowing propels nasal fluid into the paranasal sinuses.  Clin Infect Dis. 2000;  30 387-391
  • 106 Collinson J, Nicholson K G, Cancio E et al.. Effects of upper respiratory tract infections in patients with cystic fibrosis.  Thorax. 1996;  51 1115-1122
  • 107 Smyth A R, Smyth R L, Tong C Y, Hart C A, Heaf D P. Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis.  Arch Dis Child. 1995;  73 117-120
  • 108 Kumar D, Erdman D, Keshavjee S et al.. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant.  Am J Transplant. 2005;  5 2031-2036
  • 109 Garbino J, Gerbase M W, Wunderli W et al.. Respiratory viruses and severe lower respiratory tract complications in hospitalized patients.  Chest. 2004;  125 1033-1039
  • 110 Whimbey E, Champlin R E, Couch R B et al.. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients.  Clin Infect Dis. 1996;  22 778-782
  • 111 Ison M G, Hayden F G, Kaiser L, Corey L, Boeckh M. Rhinovirus infections in hematopoietic stem cell transplant recipients with pneumonia.  Clin Infect Dis. 2003;  36 1139-1143
  • 112 Hassan I A, Chopra R, Swindell R, Mutton K J. Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie Hospital experience.  Bone Marrow Transplant. 2003;  32 73-77
  • 113 Ljungman P, Ward K N, Crooks B N et al.. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.  Bone Marrow Transplant. 2001;  28 479-484
  • 114 Ghosh S, Champlin R, Couch R et al.. Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients.  Clin Infect Dis. 1999;  29 528-532
  • 115 Eccles R. Efficacy and safety of over-the-counter analgesics in the treatment of common cold and flu.  J Clin Pharm Ther. 2006;  31 309-319
  • 116 Singh M. Heated, humidified air for the common cold.  Cochrane Database Syst Rev. 2006, Issues. Art no: CD001728. DOI:1002/14651858. CDC001728 pub; 
  • 117 Rotbart H A. Antiviral therapy for enteroviruses and rhinoviruses.  Antivir Chem Chemother. 2000;  11 261-271
  • 118 Edwards M R, Kebadze T, Johnson M W, Johnston S L. New treatment regimes for virus-induced exacerbations of asthma.  Pulm Pharmacol Ther. 2006;  19 320-334
  • 119 Samo T C, Greenberg S B, Couch R B et al.. Efficacy and tolerance of intranasally applied recombinant leukocyte A interferon in normal volunteers.  J Infect Dis. 1983;  148 535-542
  • 120 Hayden F G, Gwaltney Jr J M. Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds.  J Infect Dis. 1984;  150 174-180
  • 121 Hayden F G, Gwaltney Jr J M. Intranasal interferon alpha 2 for prevention of rhinovirus infection and illness.  J Infect Dis. 1983;  148 543-550
  • 122 Douglas R M, Albrecht J K, Miles H B et al.. Intranasal interferon-alpha 2 prophylaxis of natural respiratory virus infection.  J Infect Dis. 1985;  151 731-736
  • 123 Monto A S, Shope T C, Schwartz S A, Albrecht J K. Intranasal interferon-alpha 2b for seasonal prophylaxis of respiratory infection.  J Infect Dis. 1986;  154 128-133
  • 124 Higgins P G, Phillpotts R J, Scott G M, Wallace J, Bernhardt L L, Tyrrell D A. Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteers.  Antimicrob Agents Chemother. 1983;  24 713-715
  • 125 Sasaki T, Yamaya M, Yasuda H et al.. The proton pump inhibitor lansoprazole inhibits rhinovirus infection in cultured human tracheal epithelial cells.  Eur J Pharmacol. 2005;  509 201-210
  • 126 Jang Y J, Kwon H J, Lee B J. Effect of clarithromycin on rhinovirus-16 infection in A549 cells.  Eur Respir J. 2006;  27 12-19
  • 127 Hayden F G, Herrington D T, Coats T L Pleconaril Respiratory Infection Study Group et al. Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials.  Clin Infect Dis. 2003;  36 1523-1532
  • 128 Patick A K, Brothers M A, Maldonado F et al.. In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease.  Antimicrob Agents Chemother. 2005;  49 2267-2275
  • 129 Hayden F G, Turner R B, Gwaltney J M et al.. Phase II randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers.  Antimicrob Agents Chemother. 2003;  47 3907-3916
  • 130 Schoop R, Klein P, Suter A, Johnston S L. Echinacea in the prevention of induced rhinovirus colds: a meta-analysis.  Clin Ther. 2006;  28 174-183
  • 131 Sperber S J, Shah L P, Gilbert R D, Ritchey T W, Monto A S. Echinacea purpurea for prevention of experimental rhinovirus colds.  Clin Infect Dis. 2004;  38 1367-1371
  • 132 Turner R B. Ineffectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus colds.  Clin Infect Dis. 2001;  33 1865-1870
  • 133 Kurugöl Z, Akilli M, Bayram N, Koturoglu G. The prophylactic and therapeutic effectiveness of zinc sulphate on common cold in children.  Acta Paediatr. 2006;  95 1175-1181
  • 134 Turner R B, Hendley J O. Virucidal hand treatments for prevention of rhinovirus infection.  J Antimicrob Chemother. 2005;  56 805-807
  • 135 Turner R B, Biedermann K A, Morgan J M, Keswick B, Ertel K D, Barker M F. Efficacy of organic acids in hand cleansers for prevention of rhinovirus infections.  Antimicrob Agents Chemother. 2004;  48 2595-2598

Stephen B GreenbergM.D. 

Department of Medicine, Baylor College of Medicine, One Baylor Plaza

523D, Houston, TX 77030